The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.


Updates from The Motley Fool

Latest updates on Accuray from Fool.com.


Stock Performance

ARAY vs. S&P 500 | 2 Year Performance
View Interactive ARAY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Accuray.
Current Price: $5.48
Prev Close: $5.48
Open: $5.47
Bid: $5.44
Ask: $6.25
Day's Range: $5.44 - $5.54
52wk Range: $4.75 - $7.54
Volume: 345,035
Avg Vol 624,354
Market Cap: $437.69M
P/E (ttm): -18.27
EPS (ttm): -$0.30
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Accuray.
CAPS Rating 3 out of 5
 
509 Outperform
26 Underperform
CAPS All Stars
 
95 Outperform
4 Underperform

How do you think Accuray will perform against the market?



You pick for Accuray is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joshua Levine, CEO

73% Approve

Based on 26 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Accuray.

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT